Related Experiment Video
Updated: Aug 4, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Non-coding RNAs regulating mitochondrial function in cardiovascular diseases
Insights
Non-coding RNAs (ncRNAs) regulate mitochondrial function, impacting cardiovascular diseases (CVDs). Understanding these mechanisms offers potential for novel diagnostic and therapeutic strategies for heart conditions.
Area of Science:
- Biochemistry
- Molecular Biology
- Cardiology
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of death.
- Mitochondrial dysfunction is implicated in CVD pathogenesis, but mechanisms are unclear.
- Non-coding RNAs (ncRNAs) are emerging regulators in cardiovascular health and disease.
Purpose of the Study:
- To review the mechanisms of ncRNA regulation of mitochondrial function in CVD.
- To explore the role of ncRNAs in CVD progression.
- To highlight the clinical potential of ncRNAs as biomarkers and therapeutic targets for CVD.
Main Methods:
- Literature review focusing on ncRNAs, mitochondrial function, and cardiovascular diseases.
- Analysis of studies investigating ncRNA impact on mitochondrial genes and pathways.
- Synthesis of current knowledge on ncRNA clinical applications in CVD.
Main Results:
- ncRNAs, including microRNAs, long non-coding RNAs, and circular RNAs, significantly influence mitochondrial function.
- Dysregulation of specific ncRNAs contributes to the development and progression of various CVDs.
- ncRNAs demonstrate potential as diagnostic/prognostic biomarkers and therapeutic targets for CVD.
Conclusions:
- ncRNAs play critical roles in regulating mitochondrial homeostasis and are key players in CVD.
- Targeting ncRNAs involved in mitochondrial dysfunction presents a promising avenue for CVD treatment.
- Further research into ncRNA mechanisms can accelerate the development of novel CVD therapies.
Abstract:
Cardiovascular disease (CVD) is the leading cause of disease-related death worldwide and a significant obstacle to improving patients' health and lives. Mitochondria are core organelles for the maintenance of myocardial tissue homeostasis, and their impairment and dysfunction are considered major contributors to the pathogenesis of various CVDs, such as hypertension, myocardial infarction, and heart failure. However, the exact roles of mitochondrial dysfunction involved in CVD pathogenesis remain not fully understood. Non-coding RNAs (ncRNAs), particularly microRNAs, long non-coding RNAs, and circular RNAs, have been shown to be crucial regulators in the initiation and development of CVDs. They can participate in CVD progression by impacting mitochondria and regulating mitochondrial function-related genes and signaling pathways. Some ncRNAs also exhibit great potential as diagnostic and/or prognostic biomarkers as well as therapeutic targets for CVD patients. In this review, we mainly focus on the underlying mechanisms of ncRNAs involved in the regulation of mitochondrial functions and their role in CVD progression. We also highlight their clinical implications as biomarkers for diagnosis and prognosis in CVD treatment. The information reviewed herein could be extremely beneficial to the development of ncRNA-based therapeutic strategies for CVD patients.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Mitochondrial Membranes
Regulation of Expression at Multiple Steps
MicroRNAs

